Passage Bio Statistics Share Statistics Passage Bio has 3.18M
shares outstanding. The number of shares has increased by 0.02%
in one year.
Shares Outstanding 3.18M Shares Change (YoY) 0.02% Shares Change (QoQ) 0% Owned by Institutions (%) 54.45% Shares Floating 2.87M Failed to Deliver (FTD) Shares 9,599 FTD / Avg. Volume 19.3%
Short Selling Information The latest short interest is 97.13K, so 3.06% of the outstanding
shares have been sold short.
Short Interest 97.13K Short % of Shares Out 3.06% Short % of Float 4.12% Short Ratio (days to cover) 2.83
Valuation Ratios The PE ratio is -0.53 and the forward
PE ratio is -1.22.
Passage Bio's PEG ratio is
0.01.
PE Ratio -0.53 Forward PE -1.22 PS Ratio 0 Forward PS 11.4 PB Ratio 0.56 P/FCF Ratio -0.71 PEG Ratio 0.01
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Passage Bio.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 4.07,
with a Debt / Equity ratio of 0.42.
Current Ratio 4.07 Quick Ratio 4.07 Debt / Equity 0.42 Debt / EBITDA -0.41 Debt / FCF -0.53 Interest Coverage 0
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-1.08M Employee Count 60 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by -49.22% in the
last 52 weeks. The beta is 1.82, so Passage Bio's
price volatility has been higher than the market average.
Beta 1.82 52-Week Price Change -49.22% 50-Day Moving Average 6.83 200-Day Moving Average 9.25 Relative Strength Index (RSI) 53.32 Average Volume (20 Days) 49,728
Income Statement
Revenue n/a Gross Profit -3.08M Operating Income -70.4M Net Income -64.77M EBITDA -61.69M EBIT -64.77M Earnings Per Share (EPS) -21.44
Full Income Statement Balance Sheet The company has 37.57M in cash and 25.48M in
debt, giving a net cash position of 12.1M.
Cash & Cash Equivalents 37.57M Total Debt 25.48M Net Cash 12.1M Retained Earnings -659.24M Total Assets 79.2M Working Capital 40.51M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -47.96M
and capital expenditures -34K, giving a free cash flow of -47.99M.
Operating Cash Flow -47.96M Capital Expenditures -34K Free Cash Flow -47.99M FCF Per Share -15.89
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
Dividends & Yields PASG does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast The average price target for PASG is $53.5,
which is 648.3% higher than the current price. The consensus rating is "Buy".
Price Target $53.5 Price Target Difference 648.3% Analyst Consensus Buy Analyst Count 4
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Jul 14, 2025. It was a
backward
split with a ratio of 1:20.
Last Split Date Jul 14, 2025 Split Type backward Split Ratio 1:20
Scores Altman Z-Score -13.39 Piotroski F-Score 1
